A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO studyÖ. Türeci, Martin Schüler, Ahsan M. Arozullah et al.|Annals of Oncology|2019Cited by 244
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer DevelopmentYannick Boege, Inna N. Lavrik, Massimo Lopes et al.|Cancer Cell|2017Cited by 158